期刊文献+

磷酸化壳聚糖膜引导牙周组织再生的实验研究 被引量:2

An experimental study of phosphonized chitosan membrane in guiding tissue regeneration
在线阅读 下载PDF
导出
摘要 目的评价磷酸化壳聚糖膜引导牙周组织再生的效果。方法选择Beagle犬3条,采用丝线结扎及高糖饮食的方法制备慢性牙周炎模型,随机将所制备的24颗牙周炎实验牙分为一个对照组和两个实验组。A实验组使用磷酸化壳聚糖膜,B实验组放置载药的磷酸化壳聚糖膜,C组仅给予翻瓣术作为对照组。术后12周,病理切片组织学观察,统计学分析相关数据。结果动物实验发现新生牙槽骨、牙骨质和结缔组织附着分别为:A实验组:(1.22±0.15)mm、(1.00±0.15)mm、(1.72±0.17)mm,B实验组:(1.44±0.14)mm、(1.20±0.19)mm、(2.27±0.18)mm,C空白对照组:(0.56±0.16)mm、(0.51±0.14)mm、(1.27±0.16)mm。A组和B组牙周组织修复再生的效果好于C组,B组好于A组,差异具有统计学意义(P<0.05)。结论磷酸化壳聚糖膜可以有效促进牙周组织再生与修复;载入抗菌药物后,效果更明显。 Objective To evaluate the effects of posphonized chitosan membrane in guiding tissue regeneration. Methods Three dogs were used to create chronic periodontitis model by surgically placing silk ligaments and high sugar diet, and 24 experimental teeth were randomly assigned to one control group and two treatment groups. The control group was treated by flap operation only( C group). One of the treatment groups was cured by guiding tissue regeneration with phosphonized chitosan membrane ( A group), another was cured by guiding tissue regeneration with drug-loaded phosphonized chitosan membrane( B group). The animals were sacrificed at 12 weeks after surgery for histological analysis. Results The amount of new alveolar bone formation, new cementum formation, new connective tissue adhesion in the A group was ( 1.22 ± 0. 15 ) mm, ( 1.00 ± 0. 15 ) mm, ( 1.72 ± 0. 17 ) mm, respectively. The Bgroup:(1.44±0.14)mm,(1.20±0.19)mm,(2.27±0.18)mm;the C group: (0.56±0.16)mm, (0.51 ±0. 14)mm,( 1.27 ±0. 16) mm. New periodontal tissue formation in the experimental groups were significantly higher than that in the control group. The difference was also significant between the two experimental groups (P 〈 0. 05). Conclusion Phosphonized chitosan membrane can be used as a biological material for GTR, and the effect of promoting periodontal tissue regeneration may be more obvious after drug-loaded.
出处 《安徽医科大学学报》 CAS 北大核心 2009年第5期573-576,共4页 Acta Universitatis Medicinalis Anhui
基金 安徽省教育厅自然科学基金(编号:2006kj310B) 安徽省自然科学基金(编号:070413145) 国家自然科学基金(编号:30772440)
关键词 引导组织再生 牙周 壳聚糖 guided tissue regeneration periodontal chitosan
  • 相关文献

参考文献13

  • 1蒋勇,李炯,李全利,周健.甲壳质的衍生物合成生物膜的结构和功能[J].安徽医科大学学报,2008,43(2):157-160. 被引量:4
  • 2Hasegawa H,Naganuma K,Nakagawa Y,et al.Membrane filter (pore size,0.22~0.45 micro m; thickness,150 microm) passing-through activity of pseudomonas aeruginosa and other bacterial species with indigenous infiltration ability[J].FEMS Microbiology Letters,2003,223(1):41-6.
  • 3Lee Y M,Park Y J,Lee S J,et al.Tissue engineered bone formation using chitosan/tricalcium phosphate sponges[J].J Periodontol,2000,71:410-7.
  • 4Amaral I F,Lamghari M,Sousa S R,et al.Rat bone marrow stromal cell osteogenic differentiation and fibronectin adsorption on chitosan membranes:the effect of the degree of acetylation[J].J Biomed Mater Res A,2005,75(2):387-97.
  • 5Ming Kuo S,Jen Chang S,Ting Hsu Y,et al.Evaluation of alginate coated chitosan membrane for guided tissue regeneration[J].Conf Proc IEE Eng Med Biol Soc,2005,5:4878-81.
  • 6段开文,谭葆春,史朋,吴恩格,张明珠.壳聚糖复合药膜的研制及实验研究[J].实用口腔医学杂志,2005,21(1):102-105. 被引量:21
  • 7Park J S,Choi S H,Moon I S,et al.Eight-week histological analysis on the effect of chitosan on surgically created one-wall intrabony defects in beagle dogs[J].J Clin Periodontol,2003,30(5):443-53.
  • 8Wang X,Ma J,Wang Y,et al.Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements[J].Biomaterials,2001,22(16):2247-55.
  • 9董岩,张群正,李小玲,管伟伟.壳聚糖在药物载体中的应用进展[J].现代食品科技,2007,23(7):98-100. 被引量:3
  • 10孙敬方.动物实验方法学[M].北京:北京人民卫生出版社,2005:27.

二级参考文献54

  • 1史凤芹,于世凤,庞淑珍.牙周炎动物模型初步研究[J].中华口腔医学杂志,1994,29(1):50-52. 被引量:21
  • 2姚向前,马绪臣,张震康.兔下颌骨髁状突软骨细胞的分离、培养和鉴定[J].北京医科大学学报,1996,28(6):436-438. 被引量:13
  • 3[1]Pantaleone D,Yapani M.Unusual susceptibility of chitosan to enzyme hydrolysis[J].Carbohydrate Research,1992,237:325
  • 4[2]Felt O,Furrer P,Mayer J M,et al.Topical use of chitosan in ophthalmology:tolerance assessment and evaluation of precornealretention[J].Int Pharm,1999,180(2):185
  • 5[3]Panyam J,Labhasetwar V.Biodegradable nanoparticles for drug and gene delivery to cells and tissue[J].A dv Drug Rev,2003,55:329
  • 6[4]Kawashima Y.Nanoparticulate systems for improved drug delivery[J].A dv Drug Dev,2001,47:1
  • 7[5]Tanina B,Susmita M,A jay KS,et al.Preparation characterization and biodistribution of ultrafine chitosan nanoparticles[J].Int J Pharm,2002,242:93
  • 8[6]Kevin AJ,Marie PF,Ana M,et al.Chitosan nanoparticles as delivery systems for doxorubicin[J].J Control Release,2001,73:255
  • 9[7]Mitra S,Gaur U,Ghosh PC,et al.Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier[J].J Control Release,2001,74:317
  • 10[8]Mao FL,Wu YB,Shyu SS,et al.Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery[J].J Biomed Mater Res,2002,59(3):438

共引文献35

同被引文献61

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部